The presence of CH in cases with thrombocytosis did not impact OS, illustrating the favorable prognosis for patients diagnosed with ET.47,48 However, we found a near-significant protective effect of DNMT3A mutations on OS in thrombocytosis cases. This evidence concerns the gene DNMT3A and thrombocytosis disease.